|
1LCY
Crystal Structure of the Mitochondrial Serine Protease HtrA2
Deposited 2002-04-07
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
134–458(325 aa)
|
Mutation:S173A
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5.8;295 K;lithium sulfate, sodium chloride, pH 5.8, VAPOR DIFFUSION, HANGING DROP, temperature 295K
|
Resolution 2.00 Å
R-free 0.274
|
|
1LCY
Crystal Structure of the Mitochondrial Serine Protease HtrA2
Deposited 2002-04-07
|
Different construct
Different mutation/modification
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein homooligomer
Homooligomer;Protein × 3
PDB declaration: trimeric
|
Chain A
134–458(325 aa)
|
Mutation:S173A
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5.8;295 K;lithium sulfate, sodium chloride, pH 5.8, VAPOR DIFFUSION, HANGING DROP, temperature 295K
|
Resolution 2.00 Å
R-free 0.274
|
|
2PZD
Crystal Structure of the HtrA2/Omi PDZ Domain Bound to a Phage-Derived Ligand (WTMFWV)
Deposited 2007-05-17
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain A
359–458(100 aa)
Chain B
359–458(100 aa)
|
Not recorded
|
EDO 1,2-ETHANEDIOL × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;pH 5.6;292 K;0.1 M sodium citrate, 1.0 M monoammonium dihydrogen phosphate, pH 5.6, VAPOR DIFFUSION, temperature 292K
|
Resolution 2.75 Å
R-free 0.254
|
|
5FHT
HtrA2 protease mutant V226K
Deposited 2015-12-22
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
134–458(325 aa)
|
Not recorded
|
MES 2-(N-MORPHOLINO)-ETHANESULFONIC ACID × 1
CL CHLORIDE ION × 1
K POTASSIUM ION × 1
NA SODIUM ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;293 K;MES, NaCl, KH2PO4, NaH2PO4
|
Resolution 1.95 Å
R-free 0.228
|
|
5M3N
HTRA2 wild-type structure
Deposited 2016-10-15
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 3
PDB declaration: trimeric
|
Chain A
134–458(325 aa)
|
Not recorded
|
MES 2-(N-MORPHOLINO)-ETHANESULFONIC ACID × 3
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;pH 6;293 K;Crystals were grown using the sitting drop vapor-diffusion method by mixing equal volumes of protein (10-15 mg/mL) and reservoir solution containing 0.1 M MES pH 6.0, 1 M LiCl, and 15-20% (w/v) PEG-6000
|
Resolution 1.65 Å
R-free 0.175
|
|
5M3O
HTRA2 A141S mutant structure
Deposited 2016-10-15
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 3
PDB declaration: trimeric
|
Chain A
134–458(325 aa)
|
Mutation:Mutation A141S
|
MES 2-(N-MORPHOLINO)-ETHANESULFONIC ACID × 3
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6;293 K;0.1 M MES pH 6.0, 1 M LiCl, and 15-20% (w/v) PEG-6000
|
Resolution 1.70 Å
R-free 0.200
|
|
5TNY
HTRA2 G399S mutant
Deposited 2016-10-15
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 3
PDB declaration: trimeric
|
Chain A
134–458(325 aa)
|
Mutation:G399S
|
MES 2-(N-MORPHOLINO)-ETHANESULFONIC ACID × 3
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6;293 K;0.1 M MES pH 6.0, 1 M LiCl, and 15-20% (w/v) PEG-6000
|
Resolution 1.70 Å
R-free 0.187
|
|
5TNZ
HtrA2 S142D mutant
Deposited 2016-10-15
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 3
PDB declaration: trimeric
|
Chain A
134–458(325 aa)
Fragment:UNP residues 134-458
|
Mutation:S142D
|
MES 2-(N-MORPHOLINO)-ETHANESULFONIC ACID × 3
NA SODIUM ION × 3
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6;293 K;0.1 M MES pH 6.0, 1 M LiCl, and 15-20% (w/v) PEG-6000
|
Resolution 1.75 Å
R-free 0.172
|
|
5TO0
HTRA2 S276C mutant
Deposited 2016-10-15
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 3
PDB declaration: trimeric
|
Chain A
134–458(325 aa)
|
Mutation:Mutation S276C
|
MES 2-(N-MORPHOLINO)-ETHANESULFONIC ACID × 3
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6;293 K;0.1 M MES pH 6.0, 1 M LiCl, and 15-20% (w/v) PEG-6000
|
Resolution 1.90 Å
R-free 0.177
|
|
5TO1
HtrA2 exposed (L266R, F303A) mutant
Deposited 2016-10-15
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 3
PDB declaration: trimeric
|
Chain A
134–458(325 aa)
|
Mutation:L266R and F303A
|
MES 2-(N-MORPHOLINO)-ETHANESULFONIC ACID × 3
CL CHLORIDE ION × 6
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6;293 K;0.1 M MES pH 6.0, 1 M LiCl, and 15-20% (w/v) PEG-6000
|
Resolution 1.69 Å
R-free 0.198
|
|
5WYN
HtrA2 Pathogenic Mutant
Deposited 2017-01-13
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 3
PDB declaration: trimeric
|
Chain A
134–458(325 aa)
|
Mutation:S143C,Y295W
|
CL CHLORIDE ION × 18
MES 2-(N-MORPHOLINO)-ETHANESULFONIC ACID × 3
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;295 K;Sodium phosphate monobasic monohydrate
Potassium phosphate monobasic
Sodium chloride
|
Resolution 2.05 Å
R-free 0.185
|
|
8AUK
Cryo-EM structure of human BIRC6 in complex with HTRA2.
Deposited 2022-08-25
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain C
134–458(325 aa)
Chain D
134–458(325 aa)
Chain E
134–458(325 aa)
|
Mutation:S306A
Mutation:S306A
Mutation:S306A
|
ZN ZINC ION × 2
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 6.20 Å
|
|
8E2K
Cryo-EM structure of BIRC6/HtrA2-S306A
Deposited 2022-08-15
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain X
134–458(325 aa)
Chain Y
134–458(325 aa)
Chain Z
134–458(325 aa)
|
Not recorded
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.4
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.21 Å
|